Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Sources: Neelakantan et al., Biochem Pharmacol 2018 | Dimet-Wiley et al., Sci Rep 2024 Security Profile & Chemical Identity Molecular specifications and preclinical safety data 5-Amino-1MQ Chemical Identity A small molecule derived from quinolinium salts, developed at the University of Texas (2017) 5-Amino-1MQ Tolerance & Status Safety data from preclinical studies (DIO mouse model) Published Preclinical Data 3 key studies published in Biochemical Pharmacology and Scientific Reports 35% Reduction of white adipose tissue in 11 days (20 mg/kg, 3 times/day) Physical Effects (11 days) + 40 % Improvement of grip strength in aged mice (22-24 months) Strength & Performance (aged mice) microbiome The combination of 5-Amino-1MQ + caloric restriction establishes a distinct gut microbial profile Protocol & Results Important Notice Search Only Not intended for human consumption
Some individuals also report experiencing relief from seasonal allergies, sinusitis, and upper respiratory tract infections
quick to administer Slower absorption may provide a prolonged effect Suitable for self-injection under a providers guidance (if permitted) Considerations: Localized soreness possible at injection site Slightly lower bioavailability than IV, but still effective Who It's For: Individuals seeking consistent access to glutathione without the time commitment or discomfort of IV therapy
Both compounds gastrointestinal effects are dose-related and both trial programmes titrate slowly for that reason, so pairing them stacks an effect that no monitored study has characterised
Alharthy FH, Alsughayyir J, Alfhili MA
US$ 22.74
US$ 21.20
US$ 24.03
US$ 25.15
US$ 27.50
US$ 27.54
